TABLE OF CONTENTS
1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF THE ASIA PACIFIC POLYVINYLPYRROLIDONE (PVP) MARKET 40
1.4 LIMITATIONS 41
1.5 MARKETS COVERED 42
2 MARKET SEGMENTATION 46
2.1 MARKETS COVERED 46
2.2 GEOGRAPHICAL SCOPE 47
2.3 YEARS CONSIDERED FOR THE STUDY 48
2.4 CURRENCY AND PRICING 48
2.5 DBMR TRIPOD DATA VALIDATION MODEL 49
2.6 GRADE LIFE LINE CURVE 52
2.7 MULTIVARIATE MODELING 53
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
2.9 DBMR MARKET POSITION GRID 56
2.10 MARKET END-USER COVERAGE GRID 57
2.11 DBMR MARKET CHALLENGE MATRIX 58
2.12 DBMR VENDOR SHARE ANALYSIS 59
2.13 IMPORT-EXPORT DATA 60
2.14 SECONDARY SOURCES 61
2.15 ASSUMPTIONS 62
3 EXECUTIVE SUMMARY 63
4 PREMIUM INSIGHTS 65
4.1 PESTLE ANALYSIS 66
4.1.1 POLITICAL FACTORS 66
4.1.2 ECONOMIC FACTORS 66
4.1.3 SOCIAL FACTORS 67
4.1.4 TECHNOLOGICAL FACTORS 67
4.1.5 LEGAL FACTORS 67
4.1.6 ENVIRONMENTAL FACTORS 67
4.2 PORTERS FIVE FORCES: 68
4.2.1 THREAT OF NEW ENTRANTS: 68
4.2.2 THREAT OF SUBSTITUTES: 68
4.2.3 CUSTOMER BARGAINING POWER: 69
4.2.4 SUPPLIER BARGAINING POWER: 69
4.2.5 INTERNAL COMPETITION (RIVALRY): 69
4.3 CLIMATE CHANGE SCENARIO 70
4.3.1 ENVIRONMENTAL CONCERNS 70
4.3.2 INDUSTRY RESPONSE 70
4.3.3 GOVERNMENTS ROLE 70
4.3.4 ANALYST RECOMMENDATION 70
4.4 LIST OF KEY PATENTS LAUNCHED 71
4.5 SUPPLY CHAIN ANALYSIS 72
4.6 VENDOR SELECTION CRITERIA 74
5 MARKET OVERVIEW 75
5.1 DRIVERS 77
5.1.1 APPLICATION AS EXCIPIENT IN PHARMACEUTICAL PRODUCTS 77
5.1.2 GROWTH IN THE FAST-MOVING CONSUMER GOODS INDUSTRY 77
5.1.3 INCREASE IN DEMAND FROM END-USER INDUSTRIES 78
5.2 RESTRAINTS 78
5.2.1 VOLATILITY IN RAW MATERIAL PRICES 78
5.2.2 USAGE OF HARMFUL CHEMICALS IN POLYVINYLPYRROLIDONE PRODUCTION 79
5.3 OPPORTUNITIES 79
5.3.1 GROWTH IN RESEARCH AND DEVELOPMENT ACTIVITIES 79
5.3.2 SUPPORTIVE CHEMICAL INDUSTRY OUTLOOK IN EMERGING ECONOMIES 80
5.4 CHALLENGES 80
5.4.1 CREDIBLE THREAT OF OTHER SUBSTITUTES 80
6 ASIA PACIFIC POLYVINYLPYRROLIDONE (PVP) MARKET, BY GRADE 81
6.1 OVERVIEW 82
6.2 K30 84
6.3 K90 85
6.4 K12 86
6.5 K25 87
6.6 K17 88
6.7 K60 89
6.8 K120 90
6.9 CROSPOVIDONE 91
6.10 COPOVIDONE 92
6.11 XL-10 93
6.12 ULTRA-10 94
6.13 KOLLIDON SR 95
6.14 KOLLIDON CL 96
6.15 OTHERS 97
7 ASIA PACIFIC POLYVINYLPYRROLIDONE (PVP) MARKET, BY TYPE 99
7.1 OVERVIEW 100
7.2 MEDIUM MOLECULAR WEIGHT 101
7.3 HIGH MOLECULAR WEIGHT 101
7.4 LOW MOLECULAR WEIGHT 102
8 ASIA PACIFIC POLYVINYLPYRROLIDONE (PVP) MARKET, BY FORM 104
8.1 OVERVIEW 105
8.2 POWDER 106
8.3 LIQUID 106
9 ASIA PACIFIC POLYVINYLPYRROLIDONE (PVP) MARKET, BY APPLICATION 108
9.1 OVERVIEW 109
9.2 PHARMACEUTICAL 110
9.2.1 TABLETS 111
9.2.2 LIQUID SUSPENSIONS/OINTMENT 111
9.2.3 INJECTIONS 111
9.2.4 OTHERS 112
9.3 COSMETICS 112
9.3.1 HAIR FIXATIVE POLYMERS 113
9.3.2 SKIN CARE 113
9.3.3 ORAL CARE 113
9.3.4 PERFUMES 113
9.4 SOLVENTS 113
9.4.1 INKS 114
9.4.2 PAINTS & COATINGS 114
9.4.3 POLISHING AGENTS 114
9.5 ELECTRICAL & ELECTRONICS 115
9.5.1 BATTERIES 116
9.5.2 PCBS 116
9.5.3 OTHERS 116
9.5.3.1 SCREENS 116
9.5.3.2 CMP 116
9.6 ADHESIVES 116
9.6.1 HOT MELT ADHESIVES 117
9.6.2 SKIN ADHESIVES 117
9.6.3 THICKENERS 117
9.7 AGROCHEMICALS 118
9.8 FOOD & BEVERAGE 118
9.8.1 ALCOHOLIC 119
9.8.2 NON-ALCOHOLIC 119
9.9 MEMBRANES 119
9.9.1 WATER 120
9.9.2 HEMODIALYSIS 120
9.10 CERAMICS 120
9.11 HOME CARE 121
9.12 METAL QUENCHING 121
9.13 OTHERS 122
10 ASIA PACIFIC POLYVINYLPYRROLIDONE (PVP) MARKET, BY DISTRIBUTION CHANNEL 124
10.1 OVERVIEW 125
10.2 OFFLINE 126
10.3 ONLINE 127
11 ASIA PACIFIC POLYVINYLPYRROLIDONE (PVP) MARKET, BY REGION 128
11.1 ASIA-PACIFIC 129
11.1.1 CHINA 138
11.1.2 INDIA 142
11.1.3 JAPAN 146
11.1.4 SOUTH KOREA 150
11.1.5 AUSTRALIA & NEW ZEALAND 154
11.1.6 SINGAPORE 158
11.1.7 THAILAND 162
11.1.8 INDONESIA 166
11.1.9 MALAYSIA 170
11.1.10 PHILIPPINES 174
11.1.11 REST OF ASIA-PACIFIC 178
12 ASIA PACIFIC POLYVINYLPYRROLIDONE (PVP) MARKET: COMPANY LANDSCAPE 179
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 179
12.2 RECOGNITION 180
12.3 EVENT 180
12.4 JOINT VENTURE 180
12.5 CERTIFICATION 180
12.6 INVESTMENT 181
13 SWOT ANALYSIS 182
14 COMPANY PROFILES 183
14.1 BASF SE 183
14.1.1 COMPANY SNAPSHOT 183
14.1.2 REVENUE ANALYSIS 184
14.1.3 COMPANY SHARE ANALYSIS 184
14.1.4 PRODUCT PORTFOLIO 185
14.1.5 RECENT DEVELOPMENT 185
14.2 ASHLAND 186
14.2.1 COMPANY SNAPSHOT 186
14.2.2 REVENUE ANALYSIS 186
14.2.3 COMPANY SHARE ANALYSIS 187
14.2.4 PRODUCT PORTFOLIO 187
14.2.5 RECENT DVELOPMENT 188
14.3 NIPPON SHOKUBAI CO., LTD. 189
14.3.1 COMPANY SNAPSHOT 189
14.3.2 REVENUE ANALYSIS 189
14.3.3 COMPANY SHARE ANALYSIS 190
14.3.4 PRODUCT PORTFOLIO 190
14.3.5 RECENT DEVELOPMENT 190
14.4 BOAI NKY PHARMACEUTICALS LTD. 191
14.4.1 COMPANY SNAPSHOT 191
14.4.2 COMPANY SHARE ANALYSIS 191
14.4.3 PRODUCT PORTFOLIO 192
14.4.4 RECENT DEVELOPMENT 192
14.5 BALAJI AMINES 193
14.5.1 COMPANY SNAPSHOT 193
14.5.2 REVENUE ANALYSIS 193
14.5.3 COMPANY SHARE ANALYSIS 194
14.5.4 PRODUCT PORTFOLIO 194
14.5.5 RECENT DEVELOPMENT 194
14.6 ALFA AESAR, THERMO FISHER SCIENTIFIC 195
14.6.1 COMPANY SNAPSHOT 195
14.6.2 PRODUCT PORTFOLIO 195
14.6.3 RECENT DEVELOPMENT 195
14.7 HANGZHOU MOTTO SCIENCE & TECHNOLOGY CO., LTD. 196
14.7.1 COMPANY SNAPSHOT 196
14.7.2 PRODUCT PORTFOLIO 196
14.7.3 RECENT DEVELOPMENT 196
14.8 HUANGSHAN BONSUN PHARMACEUTICALS CO., LTD. 197
14.8.1 COMPANY SNAPSHOT 197
14.8.2 PRODUCT PORTFOLIO 197
14.8.3 RECENT DEVELOPMENT 197
14.9 JH NANHANG LIFE SCIENCES CO., LTD. 198
14.9.1 COMPANY SNAPSHOT 198
14.9.2 PRODUCT PORTFOLIO 198
14.9.3 RECENT DEVELOPMENT 198
14.10 MERCK KGAA 199
14.10.1 COMPANY SNAPSHOT 199
14.10.2 REVENUE ANALYSIS 199
14.10.3 PRODUCT PORTFOLIO 200
14.10.4 RECENT DEVELOPMENT 200
15 QUESTIONNAIRE 201
16 RELATED REPORTS 204

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.